Sarepta Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	2,198	1,902	1,243	933.01	701.89
Revenue Growth (YoY)	15.58%	52.97%	33.26%	32.93%	29.95%
Cost of Revenue	2,362	1,124	1,028	1,017	862.13
Gross Profit	-163.43	778.36	215.61	-84.07	-160.24
Selling, General & Admin	491.72	557.87	481.87	451.42	282.66
Amortization of Goodwill & Intangibles	2.62	2.41	1.56	0.71	0.71
Operating Expenses	494.34	560.28	483.43	452.14	283.37
Operating Income	-657.77	218.08	-267.82	-536.2	-443.61
Interest Expense	-1.44	-18.39	-22.01	-53.25	-63.53
Interest & Investment Income	-	30.64	36.26	16.49	0.35
Other Non Operating Income (Expenses)	-17.86	-2.85	0.62	-6.92	-0.94
EBT Excluding Unusual Items	-677.08	227.48	-252.96	-579.88	-507.72
Merger & Restructuring Charges	-42.01	-	-	-	-
Gain (Loss) on Sale of Investments	-	41.13	19.39	8.66	-4.33
Gain (Loss) on Sale of Assets	-	-	102	-	102
Other Unusual Items	16.86	-7.84	-388.53	-118.74	-8.9
Pretax Income	-702.23	260.77	-520.1	-689.96	-418.95
Income Tax Expense	11.19	25.54	15.88	13.53	-0.17
Net Income	-713.41	235.24	-535.98	-703.49	-418.78
Net Income to Common	-713.41	235.24	-535.98	-703.49	-418.78
Shares Outstanding (Basic)	100	95	92	88	81
Shares Outstanding (Diluted)	100	108	92	88	81
Shares Change (YoY)	-7.19%	16.75%	5.53%	7.75%	4.24%
EPS (Basic)	-7.13	2.47	-5.80	-8.03	-5.15
EPS (Diluted)	-7.13	2.34	-5.80	-8.03	-5.15
Free Cash Flow	-	-342.74	-577.1	-356.17	-481.66
Free Cash Flow Per Share	-	-3.18	-6.25	-4.07	-5.93
Gross Margin	-7.43%	40.92%	17.34%	-9.01%	-22.83%
Operating Margin	-29.92%	11.47%	-21.54%	-57.47%	-63.20%
Profit Margin	-32.45%	12.37%	-43.11%	-75.40%	-59.66%
Free Cash Flow Margin	-	-18.02%	-46.41%	-38.17%	-68.62%
EBITDA	-605.41	255.81	-223.43	-494.34	-405.59
EBITDA Margin	-27.54%	13.45%	-17.97%	-52.98%	-57.79%
D&A For EBITDA	52.36	37.72	44.4	41.86	38.02
EBIT	-657.77	218.08	-267.82	-536.2	-443.61
EBIT Margin	-29.92%	11.47%	-21.54%	-57.47%	-63.20%
Effective Tax Rate	-	9.79%	-	-	-
Revenue as Reported	2,198	1,902	1,243	933.01	701.89
Advertising Expenses	-	32	28.6	14.6	7.7

Source: S&P Global Market Intelligence. Standard template. Financial Sources.